Study Points

Back to Course Home
Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.

A client asks what dose of psilocybin mushrooms they should take. What is the most appropriate response?
- Decline to provide any dose information since this would constitute facilitating illegal drug use.
- Provide specific dose ranges based on research protocols since these represent evidence-based practice.
- Refer the client to online psychedelic forums where they can find dosing information.
- You cannot provide recommendations but can educate about general dose ranges, individual variability, and the importance of starting low.
No support text associated with this question.Click to Review
A client asks you to recommend a safe and trustworthy underground facilitator for psilocybin therapy. What is the most ethically appropriate response?
- Decline to provide referrals but offer to help them develop criteria for evaluating facilitators themselves.
- Give them websites where they can find facilitator directories and reviews.
- Immediately explain you cannot provide such referrals as it could constitute facilitating illegal activity.
- Provide names of facilitators you have heard positive things about, with disclaimers about legality.
No support text associated with this question.Click to Review
A client currently taking 40 mg of fluoxetine daily mentions planning to use LSD. What is the primary concern?
- Increased risk of cardiovascular complications from the interaction
- Potential for increased depression after the psychedelic experience ends
- Risk of serotonin syndrome requiring emergency intervention
- Significantly reduced or absent psychedelic effects due to SSRI blockade
No support text associated with this question.Click to Review
A client reports they had a very challenging psilocybin experience with intense fear and paranoia. They're questioning whether to try psychedelics again. What is the most evidence-based response?
- Explain that challenging experiences often produce the most growth and encourage them to try again.
- Explore what was challenging and why, what they learned from it, and what different approaches might address those factors.
- Recommend the client not use psychedelics again as they had a bad trip.
- Suggest they try a different psychedelic since they may have better experiences with other substances.
No support text associated with this question.Click to Review
A client reports using ketamine recreationally several times per week for the past six months. What medical screening is most important to recommend?
- Cardiovascular stress testing
- Cognitive function assessment
- Liver function testing
- Urological evaluation for bladder and kidney function
No support text associated with this question.Click to Review
A client with no personal history of psychotic symptoms but whose biological parent has schizophrenia asks about using ketamine for depression. What is the most appropriate response?
- Discuss the elevated risk, recommend psychiatric consultation, and explore the risk-benefit profile collaboratively.
- Inform the client that family history is an absolute contraindication and recommend against use.
- Reassure the client that family history without personal symptoms presents no additional concern.
- Suggest the client try a different psychedelic with lower risks.
No support text associated with this question.Click to Review
A client with well-controlled bipolar disorder asks about the safety of using psilocybin. They have been stable on lithium for two years. What is the most appropriate initial response?
- Discuss the elevated risks, the specific concern about lithium interactions, and recommend consultation with their psychiatrist.
- Inform them that bipolar disorder is an absolute contraindication for any psychedelic use.
- Reassure them that since they are stable, psychedelic use should be safe.
- Suggest they discontinue lithium before using psilocybin to avoid interactions.
No support text associated with this question.Click to Review
During a session, a client discloses they plan to take MDMA at a music festival next weekend. What is the priority clinical response?
- Document the disclosure and continue with the session agenda without addressing it further.
- Explore their intentions, provide harm reduction education, and discuss safety planning.
- Terminate the session and require the client to commit to abstinence before continuing therapy.
- Warn the client about legal consequences and recommend they not use illegal substances.
No support text associated with this question.Click to Review
During intake, a new client mentions using psilocybin mushrooms quarterly for "personal growth and creativity." What is the most important initial assessment focus?
- Assessing whether the client's employer or family knows about this use
- Determining if this use pattern meets criteria for substance use disorder
- Educating the client about legal consequences of Schedule I substance use
- Exploring the client's understanding of safety, contraindications, and harm reduction
No support text associated with this question.Click to Review
During integration work, a client reveals they experienced what they interpret as contact with deceased loved ones during a psilocybin session. What is the most appropriate therapeutic response?
- Explain these experiences as psychological phenomena rather than actual contact with the deceased.
- Explore the personal meaning and impact of the experience without imposing your own interpretation.
- Recommend psychiatric evaluation to rule out psychotic symptoms.
- Validate that these experiences represent genuine spiritual contact.
No support text associated with this question.Click to Review
What cardiovascular consideration is most critical when a client discloses plans to use a classic psychedelic like psilocybin or LSD?
- All clients should undergo cardiac stress testing before using psychedelics.
- Classic psychedelics cause dangerous cardiovascular effects requiring cardiac monitoring.
- Modest increases in heart rate and blood pressure mean those with serious cardiovascular disease should consult their physician.
- These substances have no cardiovascular effects and are safe for all populations.
No support text associated with this question.Click to Review
What represents an appropriate boundary when a client asks you to be present during their planned psilocybin experience?
- Agree only if the experience takes place in your office during scheduled sessions
- Agree only if they procure and self-administer psilocybin, as this represents harm reduction
- Explain this would exceed your scope of practice and professional boundaries, then help them identify appropriate support
- Report this request to your licensing board as it constitutes solicitation of illegal activity
No support text associated with this question.Click to Review
Which harm-reduction strategy has the strongest evidence base for preventing adverse psychological reactions during psychedelic experiences?
- Avoiding high doses and limiting experiences to microdosing levels only
- Ensuring a trusted, sober support person is present who can provide reassurance and grounding
- Taking benzodiazepines to reduce anxiety during the experience
- Using psychedelics only in clinical or medical settings with professional supervision
No support text associated with this question.Click to Review
Which of the following represents the most significant legal risk for clinicians working with clients who use psychedelics?
- Clients disclosing illegal drug use during therapy sessions
- Continuing to treat clients after learning about their psychedelic use
- Directly recommending specific doses or sources for obtaining psychedelics
- Providing education about harm reduction strategies for psychedelic use
No support text associated with this question.Click to Review
Which statement best describes the distinction between psychedelic-informed practice and psychedelic-assisted therapy?
- Psychedelic-informed practice focuses only on integration while psychedelic-assisted therapy includes preparation.
- Psychedelic-informed practice is legal in all states while psychedelic-assisted therapy is federally prohibited.
- Psychedelic-informed practice requires specialized certification while psychedelic-assisted therapy does not.
- Psychedelic-informed practice supports clients who use substances independently, while psychedelic-assisted therapy involves direct administration or facilitation.
No support text associated with this question.Click to Review

Back to Course Home
Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.

Complete Your CE

Psychedelic-Informed Practice: Ethics and Professional Boundaries

Study Points

A client asks what dose of psilocybin mushrooms they should take. What is the most appropriate response?

A client asks you to recommend a safe and trustworthy underground facilitator for psilocybin therapy. What is the most ethically appropriate response?

A client currently taking 40 mg of fluoxetine daily mentions planning to use LSD. What is the primary concern?

A client reports they had a very challenging psilocybin experience with intense fear and paranoia. They're questioning whether to try psychedelics again. What is the most evidence-based response?

A client reports using ketamine recreationally several times per week for the past six months. What medical screening is most important to recommend?

A client with no personal history of psychotic symptoms but whose biological parent has schizophrenia asks about using ketamine for depression. What is the most appropriate response?

A client with well-controlled bipolar disorder asks about the safety of using psilocybin. They have been stable on lithium for two years. What is the most appropriate initial response?

During a session, a client discloses they plan to take MDMA at a music festival next weekend. What is the priority clinical response?

During intake, a new client mentions using psilocybin mushrooms quarterly for "personal growth and creativity." What is the most important initial assessment focus?

During integration work, a client reveals they experienced what they interpret as contact with deceased loved ones during a psilocybin session. What is the most appropriate therapeutic response?

What cardiovascular consideration is most critical when a client discloses plans to use a classic psychedelic like psilocybin or LSD?

What represents an appropriate boundary when a client asks you to be present during their planned psilocybin experience?

Which harm-reduction strategy has the strongest evidence base for preventing adverse psychological reactions during psychedelic experiences?

Which of the following represents the most significant legal risk for clinicians working with clients who use psychedelics?

Which statement best describes the distinction between psychedelic-informed practice and psychedelic-assisted therapy?